These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18506391)

  • 1. Dopamine and Consolidation of Episodic Memory: Timing is Everything.
    Grogan J; Bogacz R; Tsivos D; Whone A; Coulthard E
    J Cogn Neurosci; 2015 Oct; 27(10):2035-50. PubMed ID: 26102227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.
    De Gennaro L; Lanteri O; Piras F; Scarpelli S; Assogna F; Ferrara M; Caltagirone C; Spalletta G
    Hum Brain Mapp; 2016 Mar; 37(3):1136-47. PubMed ID: 26704150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
    Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
    Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of response times in early-stage Parkinson's disease during emotional processing of embodied and non-embodied stimuli.
    Botta A; Pelosin E; Lagravinese G; Marchese R; Di Biasio F; Bonassi G; Terranova S; Ravizzotti E; Putzolu M; Mezzarobba S; Cosentino C; Avenanti A; Avanzino L
    Sci Rep; 2024 Jun; 14(1):13031. PubMed ID: 38844758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring reward-related attention selectivity deficits in Parkinson's disease.
    Pilgrim MJD; Ou ZA; Sharp M
    Sci Rep; 2021 Sep; 11(1):18751. PubMed ID: 34548517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metacognitive Performance, the Tip-of-Tongue Experience, Is Not Disrupted in Parkinsonian Patients.
    Oh-Lee JD; Szymkowicz SM; Smith SL; Otani H
    Parkinsons Dis; 2012; 2012():174079. PubMed ID: 22577598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuropsychology of nigrostriatal dopaminergic transmission in Parkinson's disease].
    Wallesch C
    Fortschr Neurol Psychiatr; 2011 Dec; 79(12):692-5. PubMed ID: 22009273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic substitution in Parkinson's disease.
    Müller T
    Expert Opin Pharmacother; 2002 Oct; 3(10):1393-403. PubMed ID: 12387685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of emotional memory in Parkinson's disease.
    Hälbig TD; Kopp UA; Wodarz F; Borod JC; Gracies JM; Ebersbach G; Kupsch A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1159-63. PubMed ID: 18506391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Parkinson's disease and dopamine on digit span measures of working memory.
    Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
    Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.